The prospect of very-low-nicotine cigarettes becoming the next alternative product on the US market has come a significant step closer, with the US Food and Drug Administration (FDA) issuing modified risk orders for two products from 22nd Century Group.

The company’s VLN King and VLN Menthol King, which contain around 96% less nicotine than normal combustibles, are the first to be accepted by the agency as modified risk tobacco products (MRTP).

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

Shop reports

Request a free sample of this report:

“ A boost for very-low-nicotine cigarettes as US FDA grants modified risk order ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ A boost for very-low-nicotine cigarettes as US FDA grants modified risk order ”






      The prospect of very-low-nicotine cigarettes becoming the next alternative product on the US market has come a significant step closer, with the US Food and Drug Administration (FDA) issuing modified risk orders for two products from 22nd Century Group.

      The company’s VLN King and VLN Menthol King, which contain around 96% less nicotine than normal combustibles, are the first to be accepted by the agency as modified risk tobacco products (MRTP).

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik